Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeWGSGeneDx$66.89+3.6%$78.43$24.91▼$117.75$1.91B1.94785,373 shs744,448 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceWGSGeneDx0.00%-10.41%-5.48%-31.64%+124.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationWGSGeneDx3.6984 of 5 stars3.42.00.00.02.05.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceWGSGeneDx 2.75Moderate Buy$86.7529.69% UpsideCurrent Analyst Ratings BreakdownLatest WGS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.005/1/2025WGSGeneDxWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.00(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookWGSGeneDx$330.14M5.78N/AN/A$8.78 per share7.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateWGSGeneDx-$175.77M-$1.41N/A32.00N/A-17.12%3.33%1.69%7/29/2025 (Estimated)Latest WGS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioWGSGeneDx0.252.402.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipWGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipWGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableWGSGeneDx1,20028.53 million19.97 millionOptionableWGS HeadlinesRecent News About These Companies3 Medical Services Stocks Capitalizing on the Healthcare AI BoomJune 16 at 12:11 PM | zacks.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law FirmJune 16 at 11:41 AM | prnewswire.comOversold Conditions For GeneDx Holdings (WGS)June 15 at 4:19 PM | nasdaq.comGeneDx, WGS, to rise 3,300% at the open - no, don’t do anything about itJune 14 at 8:47 PM | dhakatribune.comAssenagon Asset Management S.A. Lowers Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)June 14 at 4:22 AM | marketbeat.comINVESTIGATION ALERT: Edelson Lechtzin LLP is investigating GeneDx Holdings Corp. (NASDAQ: WGS) and Encourages Investors with Substantial Losses to Contact the FirmJune 13 at 4:54 PM | prnewswire.com15,937 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Harbor Capital Advisors Inc.June 13 at 3:55 AM | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law FirmJune 12, 2025 | prnewswire.comRosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action Investigation – WGSJune 12, 2025 | businesswire.comThese 24 Stocks Are Ripe for a Short SqueezeJune 12, 2025 | schaeffersresearch.comGeneDx (NASDAQ:WGS) Trading Down 3.8% - Here's What HappenedJune 12, 2025 | marketbeat.comGAMMA Investing LLC Grows Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)June 12, 2025 | marketbeat.comWGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law FirmJune 11, 2025 | businesswire.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCJune 10, 2025 | marketbeat.comKevin Feeley Sells 370 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockJune 4, 2025 | marketbeat.comInsider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells 370 Shares of StockJune 4, 2025 | insidertrades.comBank of America Corp DE Lowers Position in GeneDx Holdings Corp. (NASDAQ:WGS)June 4, 2025 | marketbeat.comWellington Management Group LLP Invests $10.82 Million in GeneDx Holdings Corp. (NASDAQ:WGS)June 3, 2025 | marketbeat.comSquarepoint Ops LLC Sells 34,840 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)June 2, 2025 | marketbeat.comProShare Advisors LLC Buys Shares of 3,598 GeneDx Holdings Corp. (NASDAQ:WGS)June 1, 2025 | marketbeat.comMillennium Management LLC Trims Stock Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)May 31, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWGS Company DescriptionsGeneDx NASDAQ:WGS$66.89 +2.32 (+3.59%) Closing price 04:00 PM EasternExtended Trading$66.74 -0.15 (-0.22%) As of 07:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
